Sep32015

Addario Lung Cancer Foundation and Schmidt Legacy Foundation Partner to Drive Lung Cancer Research

Posted by Kassy Perry

Collaboration on 5K will raise funding for the Genomics of Young Lung Cancer study

SAN CARLOS, Calif. & CHINO HILLS, Calif – The Bonnie J. Addario Lung Cancer Foundation (ALCF) and Schmidt Legacy Foundation (SLF) today announced they are merging the ALCF’s 5th Annual “Your Next Step is the Cure” 5K with SLF’s “Rise for a Cure” 5K on January 24 at Bonelli Park, San Dimas, Calif. This collaboration allows both foundations to reach a broader audience, raise awareness for lung cancer patients and generate more funding to put towards research, particularly the Genomics of Young Lung Cancer (GoYLC) study.
“This collaboration reflects our two organizations’ focus on putting patients first, raising awareness for lung cancer patients across the world and increasing funding for research to improve survival rates,” said Scott Santarella, president and CEO of the ALCF. “We are honored to have the support and partnership of the Schmidt family.”

The ALCF is a patient-led, patient-driven advocacy organization committed to providing resources, education and care to all patients diagnosed with lung cancer. The ALCF’s partner organization, the Addario Lung Cancer Medical Institute (ALCMI) introduced the GoYLC study in collaboration with Barbara Gitlitz, MD, medical oncologist at the University of Southern California Norris Cancer Center, to research why lung cancer occurs in young adults.

“The GoYLC study is an incredibly important research project for thousands of young adults diagnosed with lung cancer,” said Jeff Schmidt, founder and board member at SLF. “We are passionate about supporting this study and expanding our partnership with the ALCF to support the critical education, research and care they provide to lung cancer patients across the country.”

The SLF was founded in memory of Gary R. Schmidt, and supports medical research projects, focusing primarily on lung cancer. SLF partners with leading researchers and provides the advocacy and funding to help improve care and treatment for patients with lung cancer. For two years in a row, SLF has contributed $10,000 to ALCMI’s ongoing GoYLC study and has supported Dr. Gitlitz’s work for the past several years.

For more details or to register for the 5K please visit www.lungcancerfoundation.org/events.

About the Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest international philanthropies (patient-founded, patient-focused and patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education and treatment. The Foundation’s goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006, as a 501c(3) non-profit organization and has raised nearly $25 million for lung cancer research and related programs. For those interested in learning more about ALCF, visit www.lungcancerfoundation.org and follow its activities on Twitter and Facebook.

About the Addario Lung Cancer Medical Institute

The Addario Lung Cancer Medical Institute (ALCMI), founded in 2008 as a 501c(3) non-profit organization, is a patient-centric, international research consortium driving research otherwise not possible, evidenced by ALCMI’s current clinical studies CASTLE, INHERIT EGFR T790M, and the Genomics of Young Lung Cancer. ALCMI overcomes barriers to collaboration via a world-class team of investigators from 22+ institutions in the U.S. and Europe, supported by dedicated research infrastructures such as centralized tissue banks and data systems. ALCMI directly facilitates research by combining scientific expertise found at leading academic institutions with patient access through our network of community cancer centers – accelerating novel research advancements to lung cancer patients.

About the Schmidt Legacy Foundation

The Schmidt Legacy Foundation seeks to make a difference in the lives of those who are challenged by diseases, illnesses or other hardships. We aspire to make a difference in our community by tackling challenging medical and social issues of today and tomorrow. Our current focus is to fund research that improves the quality and length of life for lung cancer patients; to raise hope and find a cure! Find more information at www.schmidtlegacyfoundation.org and follow its activities on Facebook.